PROTAC MDM2 Degrader-1 is primarily used in biomedical research to target and degrade the MDM2 protein, which plays a critical role in regulating the tumor suppressor protein p53. By degrading MDM2, this compound helps restore p53 activity, making it a valuable tool in studying cancer biology and developing potential therapeutic strategies. Its application is particularly significant in understanding p53-dependent pathways and exploring treatments for cancers where MDM2 overexpression inhibits p53 function. Researchers utilize this compound to investigate targeted protein degradation as a novel approach to cancer therapy.